CARBAMAZEPINE
- Product NDC
- 70518-3174
- 11-digit product format
- 705183174
- Labeler code
- 70518
- Product ID
- 70518-3174_e6eab6b2-5c00-87cd-e053-2995a90a9bb2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA211623
- Marketing category
- ANDA
- Marketing start
- 2021-07-27
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3174-0 | 70518317400 | 100 POUCH in 1 BOX (70518-3174-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-3174-1) | 100 pouch | 2021-07-27 | 0000-00-00 | No | No | Current |